Auto stocks, ITC-Happiest Minds merger in focus as markets open lower Sept 1

Nearly tenfold profit surge signals broad-based strength
Milky Mist's consolidated net profit jumped to ₹64.68 crore in Q1 FY27, driven by growth across its entire product portfolio.
Mark

So the market's opening down 56 points. Is that significant, or is it noise?

Mimi

It's modest—the NIFTY50 moves in hundreds of points regularly. What matters more is what's driving attention today: auto sales data, a major IT merger, and some surprising earnings.

Luke

But we should note the GIFT NIFTY is a futures contract, not the actual opening. It's a signal, not a guarantee.

Mark

Fair. So why do auto sales matter so much right now?

Mimi

Because they're a real-time read on consumer demand. July was strong, so investors want to know if that held through August, especially as we head into the festive season when people typically buy cars.

Luke

And we don't have the August numbers yet—they're being released today. So this is anticipation, not reaction.

Mark

What about the ITC-Happiest Minds deal? Is that a big story?

Mimi

It's significant in scale. You're combining two IT services companies into one entity with over 19,000 professionals. ITC Infotech is buying a 22% stake first, then absorbing the whole company.

Luke

The filing says the combined entity will have complementary capabilities, but we don't have detail on what those are or what synergies they're actually targeting. That's a gap.

Mark

And Milky Mist's earnings—nearly a tenfold profit jump. That's real, right?

Mimi

The numbers are in the regulatory filing. Consolidated net profit went from ₹6.53 crore to ₹64.68 crore year-on-year, and revenue grew 43.6%. That's not small.

Luke

But we don't know why. The filing says "healthy sales performance across the entire product portfolio," which is vague. Was there a price increase? Volume growth? A one-time gain? The source doesn't say.

Mark

So the earnings are confirmed, but the story behind them isn't.

Mimi

Exactly. We know what happened; we don't fully know why.

Luke

And on Sun Pharma's Medicaid deal—the terms are confidential, so we know they got MFN pricing and a tariff delay, but we don't know the full scope of the commitment.

Mark

So there's substance here, but also a lot of things we're not seeing.

Mimi

That's always true on earnings day. The filings give you the skeleton; the earnings calls give you the meat.

  • GIFT NIFTY futures pointed 56 points lower, casting a cautious mood over the session before a single trade was placed.
  • Auto majors including Maruti Suzuki, Tata Motors, and Hyundai were releasing August sales data — numbers that would either confirm or complicate the optimism built on July's strong passenger vehicle growth ahead of the festive season.
  • ITC Infotech's acquisition of a 22% stake from Happiest Minds founder Ashok Soota set the stage for a full merger, creating a 19,000-plus-professional IT entity with ambitions across healthcare, high-tech, and education technology.
  • Milky Mist stunned with a near-tenfold surge in quarterly net profit and a 43.6% revenue jump, signaling broad-based strength rather than a single-product windfall.
  • Sun Pharma secured a Most Favored Nation pricing agreement with US Medicaid programs and won a two-year delay on Section 232 tariffs, while Mankind Pharma quietly exited its hospitality subsidiary for ₹49 crore.
  • Juniper Green Energy expanded its renewable footprint to roughly 2,588 MWp in operational capacity, even as it cancelled a ₹7.6 crore acquisition with Welspun Corp, citing shifting conditions in the power market.

On the first day of September, Indian markets prepared to open in modest retreat, yet the surface dip belied a day dense with corporate consequence. From automobile showrooms gauging festive-season appetite to a technology merger reshaping the IT services landscape, from a dairy company's tenfold profit leap to pharmaceutical agreements spanning continents, the market's opening number was merely a threshold — what lay beyond it was a portrait of an economy in active, restless motion.

Indian markets were set to open lower on September 1, with GIFT NIFTY futures signaling a 56-point decline for the NIFTY50. Yet the modest red opening was little more than a frame around a day crowded with corporate movement across sectors.

The automobile industry commanded immediate attention. Maruti Suzuki, Tata Motors, Hyundai Motor India, and peers were releasing August sales figures — the first real measure of consumer appetite as the festive season drew near. July had delivered strong passenger vehicle growth, and the question hanging over the market was whether that momentum had survived into August.

In technology, ITC Infotech was acquiring a 22.106% stake from Happiest Minds founder Ashok Soota and his medical research entity, a precursor to a full amalgamation. The eventual combined company would employ more than 19,000 professionals globally, with stated ambitions in high-tech, healthcare, and education technology.

Dairy manufacturer Milky Mist delivered one of the session's more striking earnings disclosures. Its consolidated net profit for the first quarter of FY2026-27 surged nearly tenfold year-on-year to ₹64.68 crore, while revenue from operations climbed 43.6% to ₹973.45 crore — growth spread across its full product range rather than concentrated in any single line.

In pharmaceuticals, Mankind Pharma completed the sale of its hospitality subsidiary Broadway Hospitality Services to AKRK Projects LLP for ₹49 crore, closing the transaction on August 31. Sun Pharma, meanwhile, reached an agreement with US state Medicaid programs on Most Favored Nation pricing for its medicines and secured a delay of more than two years on Section 232 tariffs for innovative pharmaceutical products.

A notable stake transaction unfolded in biotech, where Ontario Inc sold a 2% holding in Concord Biotech for roughly ₹293.78 crore. DSP Mutual Fund absorbed a significant portion of those shares, lifting its total stake in the company to nearly 3%.

In renewable energy, Juniper Green Energy commissioned additional capacity at one of its projects, bringing its total operational footprint across subsidiaries to approximately 2,588 MWp and 500 MWh of battery storage. The company also mutually cancelled a ₹7.6 crore acquisition with Welspun Corp, citing conditions in local power demand and supply.

Taken together, these corporate threads — auto demand signals, IT consolidation, earnings surprises, pharmaceutical agreements, and energy infrastructure moves — offered a richer account of Indian business than any single index number could convey, as the market moved into the final quarter of the calendar year.

The Indian stock market was poised to open lower on Tuesday, September 1, with GIFT NIFTY futures signaling a decline of 56 points for the NIFTY50 index. But beneath the modest red opening lay a day thick with corporate action—mergers, divestitures, earnings surprises, and regulatory approvals that would shape investor sentiment across sectors.

The most immediate focus was on automobile manufacturers. Maruti Suzuki, Tata Motors, Hyundai Motor India, and their peers were set to release August sales figures, and investors were watching closely. The numbers mattered because they would offer the first real clue about consumer demand as the festive season approached. July had been strong—major passenger vehicle makers had reported robust growth—and the question now was whether that momentum had held. Monthly volumes would tell the story.

In the technology and IT services space, a significant merger was moving forward. ITC Infotech was acquiring a 22.106% stake from Happiest Minds founder Ashok Soota and his medical research entity as a precursor to a full amalgamation. Once the stake purchase closed, Happiest Minds would be folded into ITC Infotech entirely. The combined entity would employ more than 19,000 professionals globally and position itself to offer end-to-end solutions across build, intelligence, and operations—with particular ambitions in high-tech, healthcare, and education technology.

Elsewhere, Milky Mist, a dairy products manufacturer, had delivered earnings that caught attention. In the first quarter of the 2026-27 financial year, the company's consolidated net profit surged nearly tenfold year-on-year, climbing to ₹64.68 crore from ₹6.53 crore in the same quarter the prior year. Revenue from operations had jumped 43.6% to ₹973.45 crore, driven by healthy sales across its entire product portfolio. The growth was broad-based, suggesting strength across the board rather than reliance on a single product line.

In pharmaceuticals, two separate transactions were unfolding. Mankind Pharma had completed the divestment of its hospitality subsidiary, Broadway Hospitality Services Private Limited, transferring its entire 100% stake to AKRK Projects LLP and partners for ₹49 crore. The transaction closed on August 31. Separately, Sun Pharma had reached an agreement with US state Medicaid programs to extend Most Favored Nation pricing on its medicines and commit to the same pricing structure for future innovative drug launches. The agreement also recognized Sun Pharma's US market investments by delaying Section 232 tariffs on innovative pharmaceutical products for more than two years.

In the biotech sector, a significant stake change occurred. Ontario Inc, a Canadian corporate entity, sold a 2% stake in Concord Biotech—2,092,325 shares at an average price of ₹1,404.10 each, for a total of ₹293.78 crore. DSP Mutual Fund stepped in to acquire 1,288,000 shares, representing 1.23% of the company, at the same price for ₹180.86 crore. The transaction lifted DSP MF's total holding in Concord Biotech to nearly 3% from 1.75%.

In renewable energy, Juniper Green Energy Limited had commissioned additional capacity under one of its projects, bringing that facility to 177.6 megawatts peak and approximately 201 megawatt-hours of battery energy storage out of a planned 232.4 MWp and 201 MWh BESS. Across all its operations and subsidiaries, Juniper Green now had approximately 2,588 MWp and 500 MWh BESS in operational capacity. Meanwhile, the company had mutually agreed with Welspun Corp to cancel a ₹7.6 crore acquisition that had been approved in May, citing current conditions in power demand, supply, and availability at the relevant location.

As the market opened, these threads—auto demand, IT consolidation, earnings surprises, pharmaceutical deals, and energy infrastructure—would weave together to shape the day's trading. The red opening was just the frame; the substance lay in what these corporate actions signaled about the health of Indian business heading into the final quarter of the calendar year.

The combined entity, with a global workforce of over 19,000 professionals, will bring complementary capabilities to deliver a full-stack value proposition for end-to-end solutions spanning build, intelligence, and operations.
— ITC Infotech merger announcement
Milky Mist's revenue from operations jumped 43.6% year-on-year to ₹973.45 crore, supported by healthy sales performance across the entire product portfolio.
— Milky Mist regulatory filing
Quer a matéria completa? Leia o original em Upstox ↗
Fale Conosco FAQ